Description:
The National Heart, Lung, and Blood Institute (NHLBI) and the National Hemophilia
Foundation (NHF) invite applications for studies that will lead to improved
treatment of hemophilia, von Willebrand disease, and other hereditary bleeding
disorders with the ultimate goal of finding a cure for bleeding disorders. The
objectives of this program are to stimulate research to improve therapy, and
enhance understanding of immune response and safety issues related to novel
therapeutics, gene transfer or cell based therapies for bleeding disorders.
Who can apply:
Anyone/General Public
City Or Township Governments
County Governments
Federally Recognized Indian Tribal Governments
Independent School Districts
Individual/Family
Minority Group
Native American Organization
Non-Government - General
Nonprofits Having A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Nonprofits That Do Not Have A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Other Private Institution/Organization
Private Institutions Of Higher Education
Private Nonprofit Institution/Organization (Includes Institutions Of Higher Education, Hospitals)
Profit Organization
Public And State Controlled Institutions Of Higher Education
Public Housing Authorities/Indian Housing Authorities
Small Business (Less Than 500 Employees
Special District Governments
State (Includes District Of Columbia; Includes Institutions Of Higher Education And Hospitals)
U.S. Territories And Possessions (Includes Institutions Of Higher Education, Hospitals)
Eligible functional categories:
Funding Sources:
Blood Diseases and Resources Research
More Information:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-04-032.html
If you have problems accessing the full announcement, please contact:
NIH OER Webmaster
Address Info: